focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Plant Health Care Shares Wilt As It Warns On Challenging Conditions

Wed, 14th Sep 2016 09:17

LONDON (Alliance News) - Shares in Plant Health Care PLC dropped by a quarter on Wednesday as the company warned of increasingly challenging trading conditions and headwinds in its second half, and reported a widened loss for the first half of 2016.

Plant Health Care was down 28% at 19.78 pence Wednesday morning.

The agricultural biotechnology company reported a pretax loss of USD6.6 million in the half-year to June 30, widened from a pretax loss of USD3.1 million the prior year, due to higher administrative, research and development costs. Revenue fell to USD2.9 million from USD3.2 million.

Plant Health attributed the lower revenue to a milestone payment it had been paid in the prior year not repeating.

The company said that, whilst revenue in the first half from its commercial products was in line with its expectations, its full year will be hit by "challenging industry conditions" and adverse currency movements. As a result, it now expects its revenue for 2016 will fall short of market expectations.

"During the first six months of 2016, we have made further solid progress in building the sales momentum of Commercial Products; trading conditions have recently become increasingly challenging, and we expect headwinds in the second half, with continuing revenue growth anticipated in 2017," said Executive Chairman Christopher Richards in a statement.

"We are also making great strides in the development of our PREtec New Technology. With the completion of the USD10 million placement in August 2016, we are now confident of delivering first revenues from our PREtec peptide platforms and of bringing our Commercial business to profit, within our existing cash resources," Richards added.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2016 Alliance News Limited. All Rights Reserved.

Related Shares

More News
8 May 2024 14:20

TRADING UPDATES: ECO hails vaccine results; Plant Health sales down

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Allian...

8 May 2024 10:44

AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

8 May 2024 09:19

Plant Health Care FY revenues down, US sales boost YTD performance

(Sharecast News) - Peptides provider Plant Health Care said on Wednesday that although full-year revenues were down in 2023, US sales throughout the f...

22 Apr 2024 15:29

Plant Health Care hails Harpinab approval in Belgium

(Alliance News) - Plant Health Care PLC on Monday said its fertiliser product Harpinab has been approved for sale in Belgium.

16 Apr 2024 20:34

EARNINGS AND TRADING: AssetCo deputy retiring, Chapel Down ups revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.